Mozambique to assess possibility of using TB vaccine for COVID-19

Fri, Sep 4, 2020
By editor
1 MIN READ

Coronavirus Pandemic

HEALTH authorities in Mozambique will start conducting a study in this month to assess the possibility of using Tuberculosis vaccine to combat COVID-19 infections in the country, Radio Mozambique reported on Friday.

According to the report citing the research coordinator for acute respiratory infections and evasive bacterial diseases at Manhica Health Research Centre in Maputo province, the study will be carried out among health professionals.

“These studies test the hypothesis that the vaccine may have a positive effect.

“Recent results that have emerged in the world indicating that the possibility of the Tuberculosis vaccine could have a positive effect in combating COVID-19,” said Tembe.

The official explained that the study is already funded and the centre is currently waiting for authorisation.

Mozambique is also expected to be part of a larger trial of COVID-19 vaccines developed by other countries, which is already underway in the world.

“Different countries, including China and the U.S., are working to create a vaccine to end COVID-19.

“We expect our centre to be one of the institutions to be reached by the trials of these vaccines,” he said. (Xinhua/NAN)

– Sept. 4, 2020 @ 15:45 GMT |

Tags:


Nepal reaches out to other countries for jabs amid raging second wave

NEPAL is using all platforms available to reach out to the international community to procure vaccines amid the devastating…

Read More
Nigeria to reserve 50% of AstraZeneca supply due to anticipated delay

FAISAL Shuaib, executive director of the National Primary Health Care Development Agency, NPHCDA, has said that only...

Read More
India records 352,000 new daily COVID-19 cases, 2,812 deaths

INDIA on Monday saw a new global record of 352,991 daily new COVID-19 infections as a second wave of the...

Read More